The association between platelet-lymphocyte ratio and the risk of all-cause mortality in chronic kidney disease: a systematic review and meta-analysis
- 17 May 2022
- journal article
- review article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 54 (11) , 2959-2967
Abstract
Background Chronic kidney disease (CKD) patients have high levels of inflammatory mediators. These inflammatory mediators contribute to the increased risk of cardiovascular events and all-cause mortality. Platelet-lymphocyte ratio (PLR) has recently been recognized as a novel inflammatory marker and has been shown to be associated with the prognosis in CKD patients. However, the quality of these studies varies and their results are controversial. The purpose of this meta-analysis was to investigate the relationship between PLR and all-cause mortality in CKD patients. Methods A systematic literature search of PubMed, EMBASE, CENTRAL and ISI Web of Science was conducted. The databases were searched from their inception dates up to the latest issue (31 October 2021). Two reviewers independently searched the databases and screened studies. Data were extracted using a standardized collection form. Meta-analysis was performed to compare PLR values between CKD and non-CKD patients, and to investigate the association between PLR and all-cause mortality in CKD patients. This meta-analysis is reported in adherence to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Results A total of 11 studies involving 4244 participants were selected. The pooled data indicated that PLR values were significantly higher in CKD patients than non-CKD controls (weighted mean difference = 21.6, 95% CI 17.39–25.81, p < 0.01), and PLR is associated with an increased risk of all-cause mortality in CKD patients (hazard ratio = 2.49, 95% CI 1.78–3.49, p < 0.01). Conclusions Patients with CKD have higher PLR values compared to non-CKD patients. Meanwhile, PLR values were highly associated with all-cause mortality in CKD patients. PLR is a valid predictor as a clinically accessible indicator for patients with CKD.Keywords
This publication has 44 references indexed in Scilit:
- A Comparison of Systemic Inflammation-Based Prognostic Scores in Patients on Regular HemodialysisNephron Extra, 2013
- Intraindividual Interleukin-6 Variations on the Cardiovascular Prognosis of Patients with Chronic Renal DiseaseRenal Failure, 2012
- Prevalence of chronic kidney disease in China: a cross-sectional surveyThe Lancet, 2012
- The Role of Platelets in AtherothrombosisHematology-American Society Hematology Education Program, 2011
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Platelet Adhesion under FlowMicrocirculation, 2009
- Prevalence of Chronic Kidney Disease in the United StatesJAMA, 2007
- Stroke-Induced ImmunodepressionStroke, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003